earnings
confidence high
sentiment positive
materiality 0.80
Illumina Q3 revenue $1.08B flat YoY, non-GAAP EPS $1.34 beats; raises FY EPS guidance to $4.65-$4.75
ILLUMINA, INC.
2025-Q3 EPS reported
$3.29
revenue$3,184,000,000
- Q3 GAAP diluted EPS $0.98, non-GAAP diluted EPS $1.34; non-GAAP operating margin 24.5%.
- Revenue $1.08B flat YoY on reported and constant currency; returned to growth ex-China.
- FY2025 guidance raised: revenue decline narrowed to (1.5%)-(0.5%), non-GAAP EPS to $4.65-$4.75 from $4.45-$4.55.
- Repurchased 1.2M shares for $120M at avg $97.10; cash flow from ops $284M, free cash flow $253M.
- Launched new products: 5-base solution, Constellation mapped read tech, BioInsight, and Illumina Protein Prep.